Health Care Select Sector SPDR Fund (XLV)…

Home

Daily Stock Opinions and Ratings

Health Care Select Sector SPDR Fund (XLV)

163.78

+0.04 (0.02%)

as of Jul 2, 2026, 11:32:52 pm Market Open.

87 watching

Investor Insights

Jul 5, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

The Health Care Select Sector SPDR Fund (XLV-N) has garnered mixed opinions from experts, with some viewing it as a favorable option for short-term gains. Notably, one expert highlights the sector's resilience amidst uncertain political climates, particularly emphasizing GLP-1s as a significant growth area. Despite recent headwinds and being marked as the worst performing sector this year, others believe that healthcare remains a viable long-term investment, particularly with a projected rise by 2026. Experts recommend focusing on healthcare equipment and services if concerned about pharmaceutical volatility, showcasing the sector's diversified potential that could act as a hedge against market fluctuations. Overall, the prevailing sentiment suggests a cautious optimism about healthcare's future performance, especially for investors aiming to capitalize on market trends.

Consensus

Buy

Valuation

Undervalued

Similar

IHI

TOP PICK

There's been talk of change of the US healthcare system for years, but Covid is making it difficult to do that right now and makes healthcare protected from attack. Strong seasonal period right now. Elective surgeries coming back. Huge opportunity for an uptick at least until August. Yield is 1.39%.

Wealthica Track your Stocks in your Watch List

PAST TOP PICK

(A Top Pick May 07/20, Up 8%) Healthcare sector is a bit exhausted right now, and seeing relative weakness. He's walked back from it a bit. Coming up to an election, healthcare can become a political football.

TOP PICK

The healthcare sector has outperformed the S&P since February. There is a lot of money going into this sector. It tends to do well this time of year also. We also have to be more cautious in election years but it will be harder for this sector to be kicked back and forth like a football.

PAST TOP PICK

(A Top Pick May 09/19, Up 4%) Seasonality ends Oct. 24. It's been faltering lately. The US election campaign is a headwind and will continue to overhang. He may exit this.

PAST TOP PICK

(A Top Pick Sep 12/18, Down 1%) He was stopped out of this. The medical devices space is good. Biotech services, are under huge pressure. This ETF was a little too inclusive so he exited.

COMMENT

US Healthcare For knee replacements and implants he likes SNN-N. He does not prefer the ETFs, such as XLV-N, because they hold too broad of an array of companies, including the big drug companies that are under pressure. He would focus on the tool and device space instead.

PAST TOP PICK

(A Top Pick Aug 07/18, Up 1%) He was stopped out a while ago. Managed care got hit and became politicized. The sector went neutral, so he went into medical devices instead.

TOP PICK

It is defensive with a seasonal period from May first to the beginning of August. Investors get attracted to this sector at this time of the year because it is defensive. It has started to outperform the market. It is less exposed to the China/US trade deal. It is not a bad place to be. It is a place to hide out in.

TOP PICK

Buying beta. Can drop with the market but high quality market exposure. Tends to have high cash flow, large cap, robust companies, well diversified. Yield 1.6%.

TOP PICK

You want to focus your portfolio on leadership. He likes healthcare late cycle. These tend to have a higher cap. This is the largest diversified exposure in his portfolio.

TOP PICK

It's the largest by far in this space and cheap at 0.13% MER. Carries the biggies in healthcare with J&J, Pfizer as the top two holdings. It's highly liquid. He wants US dollars now, which is another plus. Also likes ZUB-T, but he prefers U.S. dollars.

TOP PICK

He feels the market is near the late stages of the bull run, but feels this balanced portfolio will continue to work well.

TOP PICK

This tends to be late stage and has been growing rapidly in the last 3-to-4 months. It is just starting to break out. Within the underlying sector, more industries are starting to do well pharma, services, distributors and hospitals are all improving and the US-based policy risk seems to be toning down. (Analysts’ price target was not provided)

BUY

A US healthcare ETF? He would buy one of the Spider sector ETF's. This one has very, very low costs, and is very liquid. It is well diversified. If you want something that has Canadian hedging, then you can buy ZUH-T from the Bank of Montréal.

BUY

The 2^nd best performing sector in the S&P 500. He likes it, but doesn't have any exposure to healthcare right now. It's a great ETF. With an $.805 Cdn dollar, he would definitely be buying the name.

Showing 31 to 45 of 64 entries

Most Recent Experts

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Kevin Simpson

Capital Wealth Planning

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Michael Hakes - CFA, MBA

Murray Wealth Group

Stephanie Link, Chief investment strategist, Hightower

Hightower

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Health Care Select Sector SPDR Fund (XLV)